Works matching IS 10872914 AND DT 2021 AND VI 35 AND IP 9
Results: 5
Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir.
- Published in:
- AIDS Patient Care & STDs, 2021, v. 35, n. 9, p. 335, doi. 10.1089/apc.2021.0106
- By:
- Publication type:
- Article
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study.
- Published in:
- AIDS Patient Care & STDs, 2021, v. 35, n. 9, p. 342, doi. 10.1089/apc.2021.0089
- By:
- Publication type:
- Article
Prevalence of U = U Awareness and Its Association with Anticipated HIV Stigma Among Low-Income Heterosexually Active Black and Latino Adults in New York City, 2019.
- Published in:
- AIDS Patient Care & STDs, 2021, v. 35, n. 9, p. 370, doi. 10.1089/apc.2021.0070
- By:
- Publication type:
- Article
Lessons Learned from the Pathways to Community Health Study to Evaluate the Transition of Care from Jail to Community for Men with HIV.
- Published in:
- AIDS Patient Care & STDs, 2021, v. 35, n. 9, p. 360, doi. 10.1089/apc.2021.0060
- By:
- Publication type:
- Article
Evaluation of an HIV Pre-Exposure Prophylaxis Referral System: From Sexual Health Center to Federally Qualified Health Center Pre-Exposure Prophylaxis Clinic.
- Published in:
- AIDS Patient Care & STDs, 2021, v. 35, n. 9, p. 354, doi. 10.1089/apc.2021.0050
- By:
- Publication type:
- Article